Peter Böhlen
Impact in
- Cellular and Molecular Neuroscience top 0.2%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
-
- Growth Hormone and Insulin-like Growth Factors
Papers in
-
- Neuropeptides and Animal Physiology 26
-
- Angiogenesis and VEGF in Cancer 46
- Fibroblast Growth Factor Research 30
- Co-authors
- Sidney Udenfriend (9 shared papers)NICHOLAS C. LING (48 shared papers)Frederick S. Esch (44 shared papers)Wallace M. Dairman (3 shared papers)Roger Guillemin (43 shared papers)Andrew Baird (25 shared papers)Paul Brazeau (31 shared papers)Daniel J. Hicklin (35 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (32 papers)Proceedings of the National Academy of Sciences (15 papers)Endocrinology (11 papers)Journal of Biological Chemistry (8 papers)Regulatory Peptides (7 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Peter Böhlen
219 papers receiving 27.1k citations
Peter Böhlen's Hit Papers
Peers
Comparison fields: 5 of 161
- Cellular and Molecular Neuroscience 3.1k
- Endocrinology, Diabetes and Metabolism 3.3k
- Molecular Biology 12.1k
- Reproductive Medicine 1.3k
- Oncology 1.9k
Countries citing papers authored by Peter Böhlen
This map shows the geographic impact of Peter Böhlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Böhlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Böhlen more than expected).
Fields of papers citing papers by Peter Böhlen
This network shows the impact of papers produced by Peter Böhlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Böhlen. The network helps show where Peter Böhlen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Böhlen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range Hit paper breakdown → | 1972 | 2471 |
| 2 | Fluorometric assay of proteins in the nanogram range Hit paper breakdown → | 1973 | 1566 |
| 3 | Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor Hit paper breakdown → | 1992 | 1340 |
| 4 | Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly Hit paper breakdown → | 1982 | 1134 |
| 5 | Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity Hit paper breakdown → | 2000 | 1019 |
| 6 | Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Hit paper breakdown → | 2002 | 915 |
| 7 | Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Hit paper breakdown → | 1985 | 643 |
| 8 | Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis Hit paper breakdown → | 2003 | 642 |
| 9 | Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Hit paper breakdown → | 1987 | 627 |
| 10 | Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. | 1999 | 587 |
| 11 | A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster Hit paper breakdown → | 1988 | 579 |
| 12 | 2002 | 540 | |
| 13 | Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. | 2001 | 488 |
| 14 | 1977 | 440 | |
| 15 | Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. | 2001 | 365 |
| 16 | 1985 | 346 | |
| 17 | Amino acid analysis with fluorescamine at the picomole level Hit paper breakdown → | 1973 | 342 |
| 18 | 1991 | 326 | |
| 19 | 1986 | 318 | |
| 20 | A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. | 2003 | 315 |
About Peter Böhlen
Peter Böhlen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Endocrinology, Diabetes and Metabolism, Spectroscopy and Analytical Chemistry, having authored 222 papers that have together received 30.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (46 papers), Growth Hormone and Insulin-like Growth Factors (32 papers), Fibroblast Growth Factor Research (30 papers), Neuropeptides and Animal Physiology (26 papers), Pancreatic function and diabetes (10 papers), Analytical Chemistry and Chromatography (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.1k citations), Endocrinology, Diabetes and Metabolism (3.3k citations), Molecular Biology (12.1k citations), Reproductive Medicine (1.3k citations) and Oncology (1.9k citations). Peter Böhlen has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Sidney Udenfriend, NICHOLAS C. LING, Frederick S. Esch, Wallace M. Dairman, Roger Guillemin, Andrew Baird, Paul Brazeau, Daniel J. Hicklin, Denis Gospodarowicz and Manfred Weigele. Their work appears in journals such as Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences, Endocrinology, Journal of Biological Chemistry and Regulatory Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.